Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2010-12-20
pubmed:abstractText
although blue dye is routinely used for lymphatic mapping, it is not used for lymphatic mapping in pregnancy-associated breast cancer, because of concern of fetal risk.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1879-1883
pubmed:author
pubmed:copyrightInfo
2011 Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
201
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
70-5
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Pharmacokinetics of methylene blue dye for lymphatic mapping in breast cancer-implications for use in pregnancy.
pubmed:affiliation
Department of Internal Medicine, Breast Diagnostic Clinic, Mayo Clinic and Mayo Foundation, Rochester, MN, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't